Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Product monograph guidance documents and notices - Canada.ca
Apr 19, 2025
legacy-hc-2025-04-21
ID 206681
Later capture
Product monograph guidance documents and notices - Canada.ca
Jan 1, 2026
hc-20260101
ID 404982
updated2 sections changed
2 sections changed0 added0 removed+3 / -4 linesChange ratio: 7%
--- +++ @@ -17,12 +17,12 @@ ). Please ensure the text 'Guidance document Preparation of the XML Product Monograph' is in the subject line of the email. [2025-03-28] Validation rules for Product Monographs in the Extensible Markup Language (XML) format Notices+New filing requirements for second language product monographs and package insert mock-ups: Notice+[2025-06-20] Notice to stakeholders – Publication of the final product monograph guidance document and master template (2024) [2024-12-23] Change in filing requirements for the extensible markup language product monograph (XML PM): Notice [2024-11-18]-Health Canada changes filing requirements for product monographs: Notice-[2023-03-10] Updated: Notice – Notification of Safety Labelling Changes to the Product Monographs of Pharmaceutical Drug Products [2020-03-23] Notice - Submissions Seeking Changes to the Product Monograph Sections: (a) Clinical Trial Adverse Drug Reactions (3.5.2 - 3.5.3) and; (b) Post-Market Adverse Drug Reactions (3.5.5)@@ -49,5 +49,4 @@ Notice: Revised Implementation Procedures for Product Monograph Guidance [2006-05-29] Page details-Date modified:-2025-03-31+2025-06-20